These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 23050415

  • 1. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A, Czarkowska-Paczek B.
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA, Rajkumar SV.
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Dec; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal gammopathies of undetermined significance.
    Kyle RA, Rajkumar SV.
    Best Pract Res Clin Haematol; 2005 Dec; 18(4):689-707. PubMed ID: 16026745
    [Abstract] [Full Text] [Related]

  • 5. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE, Turesson I, Lund SH, Lindqvist EK, Mailankody S, Korde N, Björkholm M, Landgren O, Kristinsson SY.
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
    Bladé J, Rosiñol L, Cibeira MT, de Larrea CF.
    Leukemia; 2008 Sep; 22(9):1651-7. PubMed ID: 18668131
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.
    Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK.
    Transplantation; 2011 Sep 15; 92(5):570-4. PubMed ID: 21712755
    [Abstract] [Full Text] [Related]

  • 8. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.
    Ann Hematol; 2002 Jul 15; 81(7):357-61. PubMed ID: 12185503
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P, Merlin L, Thomas C, Piette F.
    Ann Med Interne (Paris); 2002 Nov 15; 153(7):459-66. PubMed ID: 12598832
    [Abstract] [Full Text] [Related]

  • 11. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z, Krejčí M, Pour L, Sevčíková E, Křivanová A, Rehák Z, Koukalová R, Cermáková Z, Vaníček J, Sevčíková S.
    Vnitr Lek; 2014 Oct 15; 60(10):861-79. PubMed ID: 25382009
    [Abstract] [Full Text] [Related]

  • 12. [Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients].
    Salgado C, Bladé J, López-Guillermo A, Cervantes F, Montserrat E, Rozman C.
    Sangre (Barc); 1993 Oct 15; 38(5):371-4. PubMed ID: 8140498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M, Tomonaga M.
    Clin Lymphoma Myeloma Leuk; 2014 Feb 15; 14(1):18-20. PubMed ID: 24461807
    [Abstract] [Full Text] [Related]

  • 15. [Benign monoclonal gammopathy].
    Shirota T, Kondo M, Uchida H, Ito H.
    Nihon Rinsho; 1995 Mar 15; 53(3):720-4. PubMed ID: 7699912
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important.
    Berenson JR, Yellin O.
    Clin Lymphoma Myeloma; 2009 Aug 15; 9(4):311-5. PubMed ID: 19717382
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.